FDA User Fee Law Addresses Control of Synthetic Cannabinoids, Hydrocodone Combination Drugs
October 1, 2012 at 14:28:00 ET
The Food and Drug Administration Safety and Innovation Act, signed into law July 9 (Pub. L. No. 112-144), includes provisions to regulate synthetic cannabinoids, to review the scheduling of hydrocodone combination drugs and to inform Congress about problems posed by pharmacy Internet sites that violate federal or state law. The new provisions, which were attached to the annual FDA... Read More
